Acute Ischemic Stroke and Acute on Chronic Kidney Disease by Aftab, Raja Ahsan et al.
85JNMA I VOL 54 I NO. 2 I ISSUE 202 I APR-JUN 2016
Acute Ischemic Stroke and Acute on Chronic Kidney Disease
Raja ahsan aftab,1 amer Hayat Khan,1 Hadeer akram abdulRaazaq,1 azreen Syazril adnan1
1Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia.
ABSTrACT
Ischemic stroke is due to either local thrombus formation or emboli that occlude a cerebral artery, 
together with chronic kidney disease represent major mortality and morbidity. Here wer present 
a case of 53 years old Malay man, admitted to a hospital in Malaysia complaining of sudden onset 
of weakness on right sided upper and lower limb associated with slurred speech. Patient was also 
suffering from uncontrolled hypertension, hyperlipidemia, chronic kidney disease stage 4, and 
diabetes mellitus(un controlled). He was diagnosed with acute ischemic stroke with cranial nerve 
7 palsy (with right hemiparesis), acute on chronic kidney disease precipitated by dehydration and 
ACE inhibitor, and hyperkalemia. Patients with ischemic disease and chronic kidney disaese require 
constant monitering and carefull selected pharmacotherapy. Patient was placed under observation 
and was prescribed multiple pharamacotherpay to stabalise detoriating condition 
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INTrODUCTION
Cerebral artherosclerosis is a causative factor in 
most cases of ischemic stroke, although 30% are of 
unknown etiology. In carotid artherosclerosis plaques 
may rupture, resulting in collagen exposure, platelet 
aggregation, and thrombus formation. The clot may 
cause local occlusion or may dislodge and travel distally, 
eventually occluding a cerebral vessel.1 The patient may 
experience weakness on one side of the body, inability 
to speak, loss of vision, vertigo, or falling. 
Chronic kidney disease (CKD) is a progressive loss of 
function over several months to years, characterized by 
gradual replacement of normal kidney architecture with 
interstitial fibrosi.2 CKD is characterized by the level 
of kidney function, based on glomerular filtration rate 
(GFR) into stages 1 to 5, with each increasing number 
indicating a more advanced stage of the disease, as 
defined by a declining GFR.
CASE rEPOrT
A 53 years old Malay man, admitted to Hospital 
Universiti Sains Malaysia (HUSM) complaining of sudden 
onset of weakness on right sided upper and lower limb 
associated with slurred speech . patient claimed that 
there is no chest pain and shortness of breath. He also 
complained off poor orl intake for 2 weeks already 
and has on and off vomiting. patient urine output was 
still good, care taker reported that patient was on his 
way for massage where he complained of right limb 
weakness and became unbalanced, along with slurred 
speech, chest pain and assymetrical of the face. The 
patient was treated for stroke at a loccal clinic and was 
then shifted to HUSM.
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Patient is currently suffering from uncontrolled 
hypertension, hyperlipidemia, chronic kidney disease 
stage 4, and diabetes mellitus(un controlled). Subject 
has been suffering from diabetes mellitus since 11 
years.  In 2010, patient had a  stroke but recovers 
well. Subject claimed to be suffering from hypertension 
at age of 30 but was not on any medication and only 
start taking anti-hypertensive in 2003. Patient was 
diagnosed with acute ischemic stroke with cranial 
nerve 7 palsy (with right hemiparesis), acute on chronic 
kidney disease precipitated by dehydration and ACE 
inhibitor, and hyperkalemia. 
On examination they found positive loss of nasolabial 
fold. Neurological examination showed that cranial 
nerve 7 is impaired (lower motor neuron weakness 
and decrease in sensation). The impaired of cranial 
nerve 7 cause loss in the control of muscles of facial 
expression. Cranial nerves 9 and 10 are not impaired, 
thus his gag reflex is present. CT scan showed no intra 
cranial bleeding(ICB) and hypodense lession at middle 
cerebral artery (MCA).
DISCUSSION
ACE inhibitors decrease aldosterone and can increase 
serum potassium concentrations. Hyperkalemia occurs 
primarily in patients with chronic kidney disease, or 
diabetes mellitus, and in those also taking ARBs, 
NSAIDs, potassium supplements, or potassium-sparing 
diuretics.3 Current patient is suffering from chronic 
kidney disease and diabtes mellitus, and is taking 
ACE inhibitors for his hypertension. ACE inhibitors 
worsens current patient condition, and increase in 
serum potassium concentrations (5.8mmol/L). This 
precipitates patient chronic kidney disease, because it 
is widely known that chronic kidney disease can cause 
imbalance fluid and electrolyte in the body, and apart 
from that, dehydration worsen the patient condition.4 
Glomerular filtration rate (GFR) decrease in patients 
receiving ACE inhibitors because of inhibition of 
angiotensin 2 vasoconstriction on effecrent arterioles, 
and caused elevation in serum creatinine concentration 
(256μmol/L). Thus, perindopril(ACE inhibitor) is withhold 
in current patient.  To improve patient hydration status, 
doctor gave him with IV drip of dextrose and normal 
saline for 24 hourly. 
patient was given cocktail  infusion that included 
glucose, insulin and calcium gluconate, this helps to 
shift the potassium back into the cell, thus reduce the 
level of potassium in blood. Patient was also prescribed 
with oral kalamate 15 mg TDS since it is a calcium 
polystyrene sulfonate powder used as serum potassium 
lowering agent. Patient potassium level improved after 
the treatment(3.9 mmol/L).
Patient is diagnosed with acute ischemic stroke (left 
cerebrovascularaccident with right hemiparesis). The 
goal of therapy in current patient is to reduce the 
ongoing neurologic injury and decrease mortality and 
long term disability, prevent complication secondary to 
immobility and neuroogic dysfunction, and lastly prevent 
stroke recurrence. Based on the Stroke Council of The 
American Stroke Association,5 the drug treatment of 
first choice for acute ischemic stroke is IV Alteplase 
(t-PA) 0.9 mg/kg (maximum 90 mg), with 10% of the 
dose given as a bolus over 1 minute and the remainder 
infused over 60 minutes. It must be given within 4.5 
hours of stroke symptom onset. Early reperfusion with 
t-PA can significantly reduced the ultimate disability 
caused by ischemic stroke. Other alternative includes 
aspirin 325mg to be administered within 24 hrs to 48 hrs 
of the onset of stroke symptoms. Early aspirin therapy 
reduces the risk of early stroke recurrence and long 
term death and disability. If tPA is used, aspirin should 
not be given until 24-48 hours after the tPA infusion.6 
Patient was prescribed with table aspirin 150mg OD 
starting. Low effective dose of aspirin is given to avoid 
any complication of gastrointestinal bleeding.
Patient is also suffering from uncontrolled hypertension 
and diabetes mellitus type 2. Patient is prescribed tablet 
felodipine 10mg OD to control his hypertension along 
with tablet furosemide 40mg OD. Furosemide is the 
suitable diuretic agent to be used as antihypertensive 
agent as patient creatinine clearance is <30ml/min. 
Carvedilol is a good choice of beta blocker as it can 
reduce cardiovascular risk. Subcutaneous Actrapid 8 
unit TDS is presribed for his diabetes mellitus . Diabetes 
mellitus and hypertension can worsen patient chronic 
kidney disease, as uncontrolled diabetes mellitus can 
cause nephropathy and proteinuria. 
Since patient is also diagnosed hyperlipidemia, he was 
prescribed with tablet atorvastatin 20mg ON with tablet 
ezetimibe 10mg OD . Lastly, subject was on tablet 
pantoprazole 40mg OD to reduce gastric acid secretion. 
It is used as prophylaxis treatment in patient, to avoid 
stress induced ulcer.
Hypertensive patients with chronic kidney disaese 
represnts a challange to doctors in slecting an appropiate 
pharmacotherapy. Monitering of renal function and 
reational prescribing can aid in reducing mortality and 
morbidty in patients with hypertension and chronic 
kidney disase.
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